Results 351 to 360 of about 19,469,886 (406)
Some of the next articles are maybe not open access.

Drug safety evaluation of defibrotide

Expert Opinion on Drug Safety, 2012
Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), is a potentially life-threatening complication of chemotherapeutic conditioning used in preparation for hematopoietic stem-cell transplantation (SCT). Defibrotide (DF) has been shown in Phase II and III trials to improve complete response in patients with severe ...
Paul G, Richardson   +13 more
openaire   +2 more sources

Safety evaluation of hydrogenated oils

Food and Chemical Toxicology, 1990
Processed foods have become an important part of the diet in industrialized countries. Advances in technology have brought about significant changes in the production methods in the food industry and have led to an improvement in texture, colour, shelflife and taste of conventional food products and to the development of novel foods.
P M, Verschuren, J L, Zevenbergen
openaire   +2 more sources

Comprehensively analysis the failure evolution and safety evaluation of automotive lithium ion battery

eTransportation, 2021
G. Hu   +4 more
semanticscholar   +1 more source

Safety Evaluation

2021
Vitaly Herasevich, Brian Pickering
openaire   +1 more source

Safety Evaluation of Biotechnology Products

Drug Safety, 1990
Preclinical safety studies with biotechnology products are not only performed for regulatory purposes, but should first and foremost provide information about the potential toxic effects in patients. The initial toxicological experience, using standard testing procedures developed for drugs of small molecular weight, often gave disappointing results ...
openaire   +2 more sources

Field evaluation of vaccine safety

Vaccine, 2004
Surveillance of adverse events in the field represents an essential part of vaccination strategies. Safety studies conducted before vaccine licensure have often not enough power to detect rare or long-term adverse events. Furthermore, adverse events may be caused by incorrect procedures of storage or administration.
openaire   +2 more sources

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen   +2 more
exaly  

Device Safety Evaluation

2010
To an even greater extent than is the case with pharmaceuticals, the regulatory ­nonclinical safety assessment requirement (called, for devices, biocompatability evaluation) has become globally harmonized. The primary guidance for the USA, EU, and Japan and associated countries have formally become the ISO 10993 ­standards, with each having reference ...
openaire   +1 more source

An overview of real‐world data sources for oncology and considerations for research

Ca-A Cancer Journal for Clinicians, 2022
Lynne Penberthy   +2 more
exaly  

SAFETY EVALUATION OF ETHAMBUTOL

Annals of the New York Academy of Sciences, 1966
H F, Diermeier, J A, Kaiser, N, Yuda
openaire   +2 more sources

Home - About - Disclaimer - Privacy